Insider Transactions

Insider Ownership

Click on an individual's name to see their transaction history.

Insider Transaction Activity (Last 6 Months)
Aggregates Shares Price ($) Value ($)
Open Market Buys 0 -- --
Open Market Sells 0 -- --
Options Ex. & Sold 60,374 43.70 2,638,344
Net Shares 112,430 43.59 4,897,299

High Volume Traders (Last 6 Months)
Name #Buys #Sells # Options Ex. & Sold Total # Trans. Net Shares
William Stancil Starnes 0 0 2 2 29,914
Howard Harley Friedman 4 0 6 10 16,783
Michael Leonard Boguski 2 0 6 8 15,271
Edward Lewis Rand Jr. 2 0 6 8 15,156
Jeffrey Patton Lisenby 2 0 6 8 15,120

Insider Ownership
Transaction Date Name Action Shares Price ($) Value ($) Type Report Date
4/22/2019
Adkins, Kedrick David
Independent Director
Buy 14 35.02 490 Direct 4/22/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
4/22/2019
Bruce D. Angiolillo
Independent Director
Buy 36 35.02 1,261 Direct 4/22/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
4/22/2019
Samuel A. Di Piazza Jr.
Independent Director
Buy 66 40.72 2,688 Direct 4/22/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
4/22/2019
Robert E. Flowers
Independent Director
Buy 291 35.02 10,191 Direct 4/22/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
4/22/2019
Magnus James Gorrie
Independent Director
Buy 98 35.02 3,432 Direct 4/22/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
4/22/2019
Ziad R. Haydar
Independent Director
Buy 51 35.02 1,786 Direct 4/22/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
4/22/2019
John J. McMahon Jr.
Independent Director
Buy 291 35.02 10,191 Direct 4/22/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
4/22/2019
Frank Anthony Spinosa
Independent Director
Buy 98 35.02 3,432 Direct 4/22/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
4/22/2019
Thomas A. S. Wilson Jr.
Lead Independent Director
Buy 98 35.02 3,432 Direct 4/22/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
4/22/2019
Vance, Katisha T.
Independent Director
Buy 23 35.02 805 Direct 4/22/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
2/22/2019
Howard Harley Friedman
President of Healthcare Professional Liability, Chief Underw
Buy 1,302 43.70 56,897 Direct 2/26/2019
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
2/22/2019
Howard Harley Friedman
President of Healthcare Professional Liability, Chief Underw
Buy 5,107 43.70 223,176 Direct 2/26/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
2/22/2019
Howard Harley Friedman
President of Healthcare Professional Liability, Chief Underw
Buy 1,000 43.70 43,700 Direct 2/26/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
2/22/2019
Howard Harley Friedman
President of Healthcare Professional Liability, Chief Underw
Buy 2,698 43.70 117,903 Direct 2/26/2019
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
2/22/2019
Howard Harley Friedman
President of Healthcare Professional Liability, Chief Underw
Sell (1,302) 43.70 (56,897) Direct 2/26/2019
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise, or vesting of a security issued in accordance with Rule 16b-3
2/22/2019
Hendricks, Dana Shannon
Chief Financial Officer
Buy 490 43.70 21,413 Direct 2/26/2019
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
2/22/2019
Hendricks, Dana Shannon
Chief Financial Officer
Sell (260) 43.70 (11,362) Direct 2/26/2019
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise, or vesting of a security issued in accordance with Rule 16b-3
2/22/2019
Hendricks, Dana Shannon
Chief Financial Officer
Buy 260 43.70 11,362 Direct 2/26/2019
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
2/22/2019
Jeffrey Patton Lisenby
Executive VP, General Counsel, Corporate Secretary & Head of
Buy 5,316 43.70 232,309 Direct 2/26/2019
Grant award or other acquisition pursuant to Rule 16b-3(d)
2/22/2019
Jeffrey Patton Lisenby
Executive VP, General Counsel, Corporate Secretary & Head of
Buy 1,174 43.70 51,304 Direct 2/26/2019
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Copyright 2019, © S&P Global Market Intelligence  Terms of Use